We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

252 hedge funds and large institutions have $2.5B invested in Myriad Genetics in 2016 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 91 increasing their positions, 83 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 25

8% more funds holding

Funds holding: 233 → 252 (+19)

10% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 83

18% less capital invested

Capital invested by funds: $3.05B → $2.5B (-$544M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

67% less call options, than puts

Call options by funds: $8.7M | Put options by funds: $26.4M

Holders
252
Holders Change
+19
Holders Change %
+8.15%
% of All Funds
6.72%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
46
Increased
91
Reduced
83
Closed
25
Calls
$8.7M
Puts
$26.4M
Net Calls
-$17.7M
Net Calls Change
-$8.69M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$27M
2
Morgan Stanley
Morgan Stanley
New York
+$21.6M
3
RHJA
Rice Hall James & Associates
California
+$18.3M
4
Millennium Management
Millennium Management
New York
+$17.1M
5
RRAM
River Road Asset Management
Kentucky
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$81.5M
2
IAM
Iridian Asset Management
Connecticut
-$44.9M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$39.6M
4
SCM
Scopia Capital Management
New York
-$26M
5
CIM
Contrarius Investment Management
Jersey
-$17.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$4.18M +$1.43M +41,119 +43%
Prudential Financial
77
Prudential Financial
New Jersey
$4.1M +$667K +19,200 +17%
Citadel Advisors
78
Citadel Advisors
Florida
$4.04M -$591K -17,019 -11%
Truist Financial
79
Truist Financial
North Carolina
$4.02M +$169K +4,853 +4%
Macquarie Group
80
Macquarie Group
Australia
$3.98M +$2.26M +65,000 +100%
PPA
81
Parametric Portfolio Associates
Washington
$3.78M -$1.49M -42,895 -26%
Swiss National Bank
82
Swiss National Bank
Switzerland
$3.67M +$86.9K +2,500 +2%
HCM
83
Highbridge Capital Management
New York
$3.66M +$4.15M +119,475 New
ARTA
84
A.R.T. Advisors
New York
$3.65M +$3.66M +105,300 +751%
AQR Capital Management
85
AQR Capital Management
Connecticut
$3.52M +$1.49M +43,015 +60%
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
$3.48M +$187K +5,382 +5%
TA
87
Teachers Advisors
New York
$3.38M -$149K -4,289 -4%
SM
88
SLS Management
New York
$3.35M +$3.8M +109,300 New
CIP
89
Convergence Investment Partners
Florida
$3.28M +$1.94M +55,941 +109%
SCP
90
Seizert Capital Partners
Michigan
$3.22M -$87.8K -2,526 -2%
AL
91
Airain Ltd
Guernsey
$3.14M +$2.26M +65,105 +174%
TCM
92
Tieton Capital Management
Washington
$3.12M -$197K -5,667 -5%
SEI Investments
93
SEI Investments
Pennsylvania
$3.04M -$1.35M -38,870 -28%
Fisher Asset Management
94
Fisher Asset Management
Washington
$2.96M +$85.2K +2,453 +3%
UBS Group
95
UBS Group
Switzerland
$2.95M +$2.61M +75,208 +357%
Capital Fund Management (CFM)
96
Capital Fund Management (CFM)
France
$2.94M +$3.34M +96,034 New
MC
97
Maverick Capital
Texas
$2.87M +$3.26M +93,870 New
Bank of America
98
Bank of America
North Carolina
$2.82M -$327K -9,404 -9%
CIM
99
Contrarius Investment Management
Jersey
$2.77M -$17.2M -493,696 -85%
CIP
100
Chartwell Investment Partners
Pennsylvania
$2.59M +$2.94M +84,715 New
2 3
4
5 6

MYGN Hedge Fund Activity: Q2 2016 in Review

252 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q2 2016, worth a combined $2.5B — down 18% from $3.05B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new MYGN positions and 25 closed out — a net gain of 21 holders — while 91 added to existing stakes and 83 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $27M. The largest seller was RS Investment Management, exiting entirely with an estimated $81.5M sold.

  • 252 institutional investors held Myriad Genetics (MYGN) as of Q2 2016, up from 233 in Q1 2016.
  • Funds reported $2.5B of Myriad Genetics stock for Q2 2016, down 18% quarter-over-quarter.
  • 46 funds opened new Myriad Genetics positions in Q2 2016 and 25 closed out, a net change of +21 holders.
  • The largest Myriad Genetics buyer in Q2 2016 was Goldman Sachs, an estimated $27M added.
  • The largest Myriad Genetics seller in Q2 2016 was RS Investment Management, an estimated $81.5M sold.

Based on aggregated 13F filings for Q2 2016.